Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.18M Buy
2,800
+612
+28% +$244K 0.01% 130
2026
Q2
$792K Buy
2,188
+122
+6% +$41.8K 0.01% 147
2026
Q1
$727K Buy
2,066
+523
+34% +$186K 0.01% 130
2025
Q4
$528K Buy
1,543
+640
+71% +$203K 0.01% 147
2025
Q3
$255K Sell
903
-63
-7% -$18.3K 0.01% 187
2025
Q2
$285K Buy
966
+232
+32% +$65.7K 0.01% 139
2025
Q1
$206K Sell
734
-12
-2% -$3.54K 0.01% 135
2024
Q4
$219K Sell
746
-41
-5% -$12.2K 0.01% 136
2024
Q3
$251K Buy
787
+12
+2% +$3.92K 0.01% 122
2024
Q2
$258K Buy
775
+100
+15% +$29.4K 0.01% 114
2024
Q1
$202K Buy
+675
New +$198K 0.01% 121

Other funds holding AMGN

Facet Wealth's AMGN Position: Q3 2026 in Review

Facet Wealth increased its Amgen (AMGN) stake by 28% in Q3 2026, buying an estimated $244K and bringing the position to 2,800 shares worth $1.18M. The position accounts for 0.01% of the portfolio, ranked #130.

Facet Wealth first reported a position in AMGN in Q1 2024 and has held it in 11 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Facet Wealth held 2,800 shares of Amgen worth $1.18M as of Q3 2026.
  • Facet Wealth bought 612 Amgen shares in Q3 2026, an estimated $244K.
  • Amgen made up 0.01% of Facet Wealth's portfolio in Q3 2026, its #130 holding.
  • Facet Wealth first reported a position in Amgen in Q1 2024 and has held it in 11 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Facet Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.